1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. GENMAB - ADR
Genmab - ADR XNAS: GMAB

Genmab - ADR Live Share Price Today, Share Analysis and Chart

Mid-range Performer
about

Genmab is a Copenhagen-based biotechnology company specializing in antibody therapeutics for the treatment of cancer. Genmab's proprietary antibody technologies are DuoBody, HexaBody, DuoHexaBody, and HexElect. Johnson & Johnson partnered with Genmab...

Read More
21.40 -0.46 (-2.10%)
25.07% Fall from 52W High
1.2M
XNAS Volume

XNAS 11 Jul, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
High Financial Strength
55.6 / 100
Valuation Score
Mid Valuation
46.8 / 100
Momentum Score
Technically Neutral
42.1 / 100
Mid-range Performer These stocks are with strong quality. Their reasonable financials and technical aspects successfully gather investor's interest. View Similar Embed DVM
Analyst Price Target
30
1Yr Price target upside is 39%
8 analysts

12

S

6

W

3

O

1

T

SWOT Analysis

Genmab - ADR Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..